The Role of Central and Peripheral μ Opioid Receptors in Inflammatory Pain and Edema: A Study Using Morphine and DiPOA ([8-(3,3-Diphenyl-propyl)-4-oxo-1-phenyl-1,3,8-triaza-spiro[4.5]dec-3-yl]-acetic Acid)
- 3 June 2005
- journal article
- Published by American Society for Pharmacology & Experimental Therapeutics (ASPET) in The Journal of pharmacology and experimental therapeutics
- Vol. 314 (3), 1234-1240
- https://doi.org/10.1124/jpet.105.088351
Abstract
The role of opioid receptors located in the central nervous system (CNS) and peripheral nervous system in inflammatory pain is well established. In contrast, although it is has been shown that μ agonists can reduce other manifestations of inflammation, such as edema, the mechanism of action remains unclear. In this study, we have activated μ receptors located centrally, those located peripherally, and those located both centrally and peripherally and compared the effects on pain and edema using the rat carrageenan model of acute inflammation. Activation of μ receptors located only in the periphery, by administration of the peripheralized μ agonist [8-(3,3-diphenyl-propyl)-4-oxo-1-phenyl-1,3,8-triaza-spiro[4.5]dec-3-yl]-acetic acid (DiPOA) or local administration of morphine, resulted in antihyperalgesia (30 mg/kg DiPOA, 83% inhibition; 100 μg/rat morphine, 75% inhibition) without affecting edema. In contrast, activation of both central and peripheral μ receptors using systemically administered morphine resulted in antihyperalgesia (1 mg/kg, 80% inhibition) and inhibition of edema (10 mg/kg, 54% inhibition). Finally, activation of only receptors located in the CNS, by central administration of DiPOA or systemic administration of morphine after block of only the peripheral μ receptors using q-naltrexone, resulted in a significant reduction in edema. Our findings confirm the role of peripheral μ receptors in the pathology of pain associated with acute inflammation and argue against the involvement of these receptors in edema formation. Furthermore, our data demonstrate that activation of μ receptors in the brain inhibits carrageenan-induced edema and suggest that the antiedematous effect of morphine is due to action at central receptors alone.Keywords
This publication has 30 references indexed in Scilit:
- DiPOA ([8-(3,3-Diphenyl-propyl)-4-oxo-1-phenyl-1,3,8-triazaspiro[4.5]dec-3-yl]-acetic Acid), a Novel, Systemically Available, and Peripherally Restricted Mu Opioid Agonist with Antihyperalgesic Activity: II. In Vivo Pharmacological Characterization in the RatThe Journal of pharmacology and experimental therapeutics, 2004
- DiPOA ([8-(3,3-Diphenyl-propyl)-4-oxo-1-phenyl-1,3,8-triazaspiro[4.5]dec-3-yl]-acetic Acid), a Novel, Systemically Available, and Peripherally Restricted Mu Opioid Agonist with Antihyperalgesic Activity: I. In Vitro Pharmacological Characterization and Pharmacokinetic PropertiesThe Journal of pharmacology and experimental therapeutics, 2004
- Opioid-Induced Mast Cell Activation and Vascular Responses Is Not Mediated by ??-Opioid Receptors: An In Vivo Microdialysis Study in Human SkinAnesthesia & Analgesia, 2004
- Effect of morphine sulphate eye drops on hyperalgesia in the rat corneaPain, 2003
- Painful Inflammation-Induced Increase in μ-Opioid Receptor Binding and G-Protein Coupling in Primary Afferent NeuronsMolecular Pharmacology, 2003
- Peripheral Effects of Methionine-Enkephalin on Inflammatory Reactions and Behavior in the RatNeuroimmunomodulation, 2000
- Pharmacological evidence for the involvement of the endogenous opioid system in the response to local inflammation in the rat pawPain, 1995
- Opioid inhibition of Ih via adenylyl cyclaseNeuron, 1994
- Opiates suppress carrageenan-induced edema and hyperthermia at doses that inhibit hyperalgesiaPain, 1990
- Peripheral effect of fentanyl upon nociception in inflamed tissue of the ratNeuroscience Letters, 1988